MGP
BIIB icon

Metis Global Partners’s Biogen BIIB Stock Holding History

Metis Global Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
6,191
+15
+0.2% +$2.87K 0.03% 386
2026
Q1 		$1.13M Sell
6,176
-1,035
-14% -$191K 0.03% 416
2025
Q4 		$1.27M Buy
7,211
+887
+14% +$145K 0.03% 410
2025
Q3 		$886K Sell
6,324
-323
-5% -$43.7K 0.02% 501
2025
Q2 		$835K Sell
6,647
-4,005
-38% -$499K 0.02% 501
2025
Q1 		$1.46M Buy
10,652
+3,657
+52% +$523K 0.04% 381
2024
Q4 		$1.07M Sell
6,995
-1,379
-16% -$233K 0.03% 419
2024
Q3 		$1.62M Buy
8,374
+371
+5% +$77.6K 0.05% 339
2024
Q2 		$1.86M Buy
8,003
+113
+1% +$24.6K 0.06% 266
2024
Q1 		$1.7M Buy
7,890
+19
+0.2% +$4.45K 0.06% 291
2023
Q4 		$2.04M Sell
7,871
-56
-0.7% -$13.8K 0.08% 231
2023
Q3 		$2.04M Buy
7,927
+999
+14% +$267K 0.1% 213
2023
Q2 		$1.97M Sell
6,928
-87
-1% -$25.9K 0.11% 200
2023
Q1 		$1.95M Buy
7,015
+73
+1% +$20.2K 0.13% 167
2022
Q4 		$1.92M Buy
6,942
+1,620
+30% +$458K 0.17% 129
2022
Q3 		$1.42M Buy
5,322
+138
+3% +$29.3K 0.23% 102
2022
Q2 		$1.06M Buy
5,184
+2,223
+75% +$454K 0.17% 139
2022
Q1 		$623K Buy
2,961
+1,024
+53% +$223K 0.07% 246
2021
Q4 		$465K Buy
+1,937
New +$498K 0.13% 173

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Metis Global Partners's BIIB Position: Q2 2026 in Review

Metis Global Partners increased its Biogen (BIIB) stake by 0.24% in Q2 2026, buying an estimated $2.87K and bringing the position to 6,191 shares worth $1.34M. The position accounts for 0.03% of the portfolio, ranked #386.

Metis Global Partners first reported a position in BIIB in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.04M in Q3 2023. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Metis Global Partners held 6,191 shares of Biogen worth $1.34M as of Q2 2026.
  • Metis Global Partners bought 15 Biogen shares in Q2 2026, an estimated $2.87K.
  • Biogen made up 0.03% of Metis Global Partners's portfolio in Q2 2026, its #386 holding.
  • Metis Global Partners first reported a position in Biogen in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's Biogen position peaked at $2.04M in Q3 2023.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.